^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Guardant360 TissueNext™

Type:
Laboratory Developed Test
Related tests:
Guardant360 TissueNext™ is an analytically validated tissue Comprehensive Genomic Profiling (CGP) panel that includes TMB, MSI status, and PD-L1 IHC. Has turnaround time of 2-3 weeks from sample receipt to results.
Cancer:
Non Small Cell Lung Cancer
Gene:
AKT1 (V-akt murine thymoma viral oncogene homolog 1), ALK (Anaplastic lymphoma kinase), APC (APC Regulator Of WNT Signaling Pathway), AR (Androgen receptor), ARAF (A-Raf Proto-Oncogene), ARID1A (AT-rich interaction domain 1A)
See More ...
Method:
Comprehensive Genomic Profiling